GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » Long-Term Debt

Bukwang Pharmaceutical Co (XKRX:003000) Long-Term Debt : ₩78,868 Mil (As of Sep. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co Long-Term Debt?

Bukwang Pharmaceutical Co's Long-Term Debt for the quarter that ended in Sep. 2024 was ₩78,868 Mil.

Bukwang Pharmaceutical Co's quarterly Long-Term Debt increased from Mar. 2024 (₩78,628 Mil) to Jun. 2024 (₩78,747 Mil) and increased from Jun. 2024 (₩78,747 Mil) to Sep. 2024 (₩78,868 Mil).

Bukwang Pharmaceutical Co's annual Long-Term Debt stayed the same from Dec. 2021 (₩0 Mil) to Dec. 2022 (₩0 Mil) but then increased from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩78,525 Mil).


Bukwang Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Bukwang Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bukwang Pharmaceutical Co Long-Term Debt Chart

Bukwang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 78,525.13

Bukwang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30,000.00 78,525.13 78,627.77 78,746.70 78,867.82

Bukwang Pharmaceutical Co  (XKRX:003000) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Bukwang Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Bukwang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR
Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co Headlines

No Headlines